BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30955196)

  • 1. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
    Sun YH; Li J; Shu HJ; Li ZL; Qian JM
    Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
    Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
    Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of mucosal architecture using computer-based analysis of confocal laser endomicroscopy in inflammatory bowel diseases.
    Quénéhervé L; David G; Bourreille A; Hardouin JB; Rahmi G; Neunlist M; Brégeon J; Coron E
    Gastrointest Endosc; 2019 Mar; 89(3):626-636. PubMed ID: 30120955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective.
    Wasinger VC; Yau Y; Duo X; Zeng M; Campbell B; Shin S; Luber R; Redmond D; Leong RW
    Mol Cell Proteomics; 2016 Jan; 15(1):256-65. PubMed ID: 26530476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease.
    Hisamatsu T; Okamoto S; Hashimoto M; Muramatsu T; Andou A; Uo M; Kitazume MT; Matsuoka K; Yajima T; Inoue N; Kanai T; Ogata H; Iwao Y; Yamakado M; Sakai R; Ono N; Ando T; Suzuki M; Hibi T
    PLoS One; 2012; 7(1):e31131. PubMed ID: 22303484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Fragment of Collagen Type VI alpha-3 chain is Elevated in Serum from Patients with Gastrointestinal Disorders.
    Holm Nielsen S; Mortensen JH; Willumsen N; Rasmussen DGK; Mogensen DJ; Di Sabatino A; Mazza G; Jørgensen LN; Giuffrida P; Pinzani M; Klinge L; Kjeldsen J; Leeming DJ; Karsdal MA; Genovese F
    Sci Rep; 2020 Apr; 10(1):5910. PubMed ID: 32245981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red cell distribution width for assessment of activity of inflammatory bowel disease.
    Cakal B; Akoz AG; Ustundag Y; Yalinkilic M; Ulker A; Ankarali H
    Dig Dis Sci; 2009 Apr; 54(4):842-7. PubMed ID: 18716874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I; Fedak D; Mach T
    Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases.
    Kalla R; Kennedy NA; Ventham NT; Boyapati RK; Adams AT; Nimmo ER; Visconti MR; Drummond H; Ho GT; Pattenden RJ; Wilson DC; Satsangi J
    Am J Gastroenterol; 2016 Dec; 111(12):1796-1805. PubMed ID: 27596694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
    Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification.
    Lopez-Siles M; Aldeguer X; Sabat-Mir M; Serra-Pagès M; Duncan SH; Flint HJ; Garcia-Gil LJ; Martinez-Medina M
    World J Gastrointest Pathophysiol; 2020 May; 11(3):64-77. PubMed ID: 32435523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UC.
    Wang W; Wu L; Wu X; Li K; Li T; Xu B; Liu W
    Clin Chim Acta; 2021 Mar; 514():8-14. PubMed ID: 33333044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced formation of advanced oxidation protein products in IBD.
    Krzystek-Korpacka M; Neubauer K; Berdowska I; Boehm D; Zielinski B; Petryszyn P; Terlecki G; Paradowski L; Gamian A
    Inflamm Bowel Dis; 2008 Jun; 14(6):794-802. PubMed ID: 18213700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease.
    Yılmaz B; Köklü S; Yüksel O; Arslan S
    World J Gastroenterol; 2014 Aug; 20(31):10916-20. PubMed ID: 25152594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
    Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
    Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum levels of circulating immunoinflammation-related protein complexes are associated with cancer.
    Wang Y; Song G; Wang Y; Qiu L; Qin X; Liu H; Li F; Wang X; Li F; Guo S; Zhang Y; Li Z
    J Proteome Res; 2014 Feb; 13(2):710-9. PubMed ID: 24295561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.